Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The influence of endotoxemia on the molecular mechanisms of insulin resistance.

Boroni Moreira AP, de Cássia Gonçalves Alfenas R.

Nutr Hosp. 2012 Mar-Apr;27(2):382-90. doi: 10.1590/S0212-16112012000200007. Review.

2.

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R.

Diabetes. 2008 Jun;57(6):1470-81. doi: 10.2337/db07-1403. Epub 2008 Feb 27.

3.

Metabolic endotoxemia initiates obesity and insulin resistance.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R.

Diabetes. 2007 Jul;56(7):1761-72. Epub 2007 Apr 24.

4.

Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia.

Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C.

Br J Nutr. 2012 Sep;108(5):801-9. doi: 10.1017/S0007114512001213. Epub 2012 Apr 16. Review.

PMID:
22717075
5.

Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?

Esteve E, Ricart W, Fernández-Real JM.

Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d. Review.

PMID:
21681087
6.

The gut microbiota, obesity and insulin resistance.

Shen J, Obin MS, Zhao L.

Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16. Review.

PMID:
23159341
7.

Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.

Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD.

Benef Microbes. 2014 Mar;5(1):3-17. doi: 10.3920/BM2012.0065. Review.

PMID:
23886976
8.

Metabolic endotoxaemia: is it more than just a gut feeling?

Piya MK, Harte AL, McTernan PG.

Curr Opin Lipidol. 2013 Feb;24(1):78-85. doi: 10.1097/MOL.0b013e32835b4431. Review.

PMID:
23298961
9.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

10.

Of microbes and meals: the health consequences of dietary endotoxemia.

Kelly CJ, Colgan SP, Frank DN.

Nutr Clin Pract. 2012 Apr;27(2):215-25. doi: 10.1177/0884533611434934. Epub 2012 Feb 29. Review.

11.

Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.

Monte SV, Caruana JA, Ghanim H, Sia CL, Korzeniewski K, Schentag JJ, Dandona P.

Surgery. 2012 Apr;151(4):587-93. doi: 10.1016/j.surg.2011.09.038. Epub 2011 Nov 16.

PMID:
22088821
12.

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

Diamant M, Blaak EE, de Vos WM.

Obes Rev. 2011 Apr;12(4):272-81. doi: 10.1111/j.1467-789X.2010.00797.x. Epub 2010 Aug 26. Review.

PMID:
20804522
13.

Metabolic endotoxemia and diabetes mellitus: A systematic review.

Gomes JMG, Costa JA, Alfenas RCG.

Metabolism. 2017 Mar;68:133-144. doi: 10.1016/j.metabol.2016.12.009. Epub 2016 Dec 18. Review.

PMID:
28183445
14.

The role of the gut microbiota in energy metabolism and metabolic disease.

Cani PD, Delzenne NM.

Curr Pharm Des. 2009;15(13):1546-58. Review.

PMID:
19442172
15.

Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects.

Radilla-Vázquez RB, Parra-Rojas I, Martínez-Hernández NE, Márquez-Sandoval YF, Illades-Aguiar B, Castro-Alarcón N.

Obes Facts. 2016;9(1):1-11. doi: 10.1159/000442479. Epub 2016 Jan 9.

16.

Tumor necrosis factor-alpha mediates hyperglycemia-augmented gut barrier dysfunction in endotoxemia.

Yajima S, Morisaki H, Serita R, Suzuki T, Katori N, Asahara T, Nomoto K, Kobayashi F, Ishizaka A, Takeda J.

Crit Care Med. 2009 Mar;37(3):1024-30. doi: 10.1097/CCM.0b013e31819b53b6.

PMID:
19237913
17.

Intestinal microbiota in inflammation and insulin resistance: relevance to humans.

De Bandt JP, Waligora-Dupriet AJ, Butel MJ.

Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):334-40. doi: 10.1097/MCO.0b013e328347924a. Review.

PMID:
21587065
18.

Experimental endotoxemia induces adipose inflammation and insulin resistance in humans.

Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP.

Diabetes. 2010 Jan;59(1):172-81. doi: 10.2337/db09-0367. Epub 2009 Sep 30.

19.

Potential mechanisms for the emerging link between obesity and increased intestinal permeability.

Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio Mdo C.

Nutr Res. 2012 Sep;32(9):637-47. doi: 10.1016/j.nutres.2012.07.003. Epub 2012 Sep 7. Review.

PMID:
23084636
20.

Endogenous interleukin 18 suppresses hyperglycemia and hyperinsulinemia during the acute phase of endotoxemia in mice.

Yamashita H, Aoyama-Ishikawa M, Takahara M, Yamauchi C, Inoue T, Miyoshi M, Maeshige N, Usami M, Nakao A, Kotani J.

Surg Infect (Larchmt). 2015 Feb;16(1):90-6. doi: 10.1089/sur.2013.269. Epub 2015 Feb 4.

Supplemental Content

Support Center